Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms CG428 |
Target |
Action- |
Mechanism TrkA antagonists(Nerve growth factor receptor Trk-A antagonists), TrkB inhibitors(Neurotrophic tyrosine kinase receptor type 2 inhibitors), TrkC inhibitors(Neurotrophic tyrosine kinase receptor type 3 inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
License Organization- |
Drug Highest Phase- |
First Approval Date- |
Regulation- |
Molecular FormulaC43H43FN10O6 |
InChIKeyFWANKJAOTQAHHR-KWRHIPAJSA-N |
CAS Registry- |